N.C., are leading a sign-on letter urging the Centers for Medicare and Medicaid Services (CMS) not to move forward with ...

Medline may soon be ready to pull the trigger on an initial public offering (IPO), according to Bloomberg and other news outlets.

Biolinq has received De Novo Classification from the U.S. Food and Drug Administration for its lead product, Biolinq Shine, a patch on the forearm that provides real-time glucose feedback through a pr ...